Search for: "United States v. Bayer" Results 221 - 240 of 294
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2022, 2:46 pm by Kevin LaCroix
Regular readers of this blog know my view that the  rise of collective investor actions outside the United States is one of the most important developments in the world of directors’ and officers’ liability in recent years. [read post]
24 May 2007, 10:40 am
Bayer Corp., 398 F.3d 640, 643 (7th Cir. 2005) (applying Illinois law); Thomas v. [read post]
2 Aug 2012, 4:53 am by Victoria VanBuren
 The Convention came into force for the United States one month after the United States deposited its instrument of ratification with the Director-General of UNESCO. [read post]
23 Jan 2015, 9:30 am
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), and Marcus v. [read post]
24 Sep 2021, 11:59 am by Andrew Hamm
Bayer Consumer Care AG 21-195Issues: (1) Whether, in view of the principle of trademark territoriality, the zone of interests encompassed by Lanham Act Sections 43(a) and 14(3) extends to the foreign owner of a foreign trademark that has not registered or used the mark in the United States; and (2) whether, in the absence of an express limitations period in the Lanham Act, the timeliness of a Section 43(a) suit for false association and false… [read post]
14 Oct 2010, 10:11 am by Bexis
  Here’s why.We recently blogged about new United States Supreme Court certiorari grants of interest. [read post]
30 Jul 2009, 8:45 pm
United States, 909 F.2d 495, 499 (Fed. [read post]
1 May 2009, 11:00 am
(Spicy IP) Defining ‘literary works’ for copyright protection (International Law Office) Drafting and interpretation of patent claims (IP Frontline)   Israel Israel Patent Office accepts lacks jurisdiction and rules anyway: Karl Storz GmbH & Co v Bausch and Lomb (The IP Factor) Economist report ranks Israel 10th in terms of innovation (The IP Factor)   Mauritius Mauritius launches IP sensitivity drive (Afro-IP)   Netherlands Presiding… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
18 Jul 2019, 11:24 pm by Florian Mueller
But, at least for now, the related case law in the United States is fundamentally better than in Germany, though this may be attributable in no small part to the historic happenstance of what cases were put before the courts in what sequence--and what questions for review the parties raised.Just so there is no misunderstanding: Dr. [read post]
27 Aug 2010, 2:41 pm by Bexis
We disagree.In Hoffman, the United States Court of Appeals for the Third Circuit applied Pennsylvania law and concluded that there was sufficient evidence for the jury to find that the manufacturer failed to adequately test its drug to discover potentially harmful side-effects. [read post]
1 Apr 2011, 7:40 am
One -- at the crack of dawn on Monday morning -- is a chance to share a breakfast with the early-rising Head of the United States Patent and Trademark Office, David Kappos (details here). [read post]